Atherogenic L5 LDL induces cardiomyocyte apoptosis and inhibits KATP channels through CaMKII activation

Abstract Background Cardiac Ca2+/calmodulin-dependent protein kinase II (CaMKII) activation plays a critical role in cardiomyocyte (CM) apoptosis and arrhythmia. Functional ATP-sensitive potassium (KATP) channels are essential for cardiac protection during ischemia. In cultured CMs, L5 low-density l...

Full description

Bibliographic Details
Main Authors: Yanzhuo Ma, Nancy Cheng, Junping Sun, Jonathan Xuhai Lu, Shahrzad Abbasi, Geru Wu, An-Sheng Lee, Tatsuya Sawamura, Jie Cheng, Chu-Huang Chen, Yutao Xi
Format: Article
Language:English
Published: BMC 2020-08-01
Series:Lipids in Health and Disease
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12944-020-01368-7
id doaj-3aa2b3b2282f4b0abf2094735a47f5d3
record_format Article
spelling doaj-3aa2b3b2282f4b0abf2094735a47f5d32020-11-25T03:49:14ZengBMCLipids in Health and Disease1476-511X2020-08-0119111010.1186/s12944-020-01368-7Atherogenic L5 LDL induces cardiomyocyte apoptosis and inhibits KATP channels through CaMKII activationYanzhuo Ma0Nancy Cheng1Junping Sun2Jonathan Xuhai Lu3Shahrzad Abbasi4Geru Wu5An-Sheng Lee6Tatsuya Sawamura7Jie Cheng8Chu-Huang Chen9Yutao Xi10Department of Cardiology, Bethune International Peace HospitalCardiac Electrophysiology Research Laboratory, Texas Heart InstituteCardiac Electrophysiology Research Laboratory, Texas Heart InstituteVascular and Medicinal Research, Texas Heart InstituteMolecular Cardiology Research, Texas Heart InstituteCardiac Electrophysiology Research Laboratory, Texas Heart InstituteDepartment of Medicine, Mackay Medical CollegeDepartment of Life Innovation, Institute for Biomedical Sciences, Shinshu UniversityCardiac Electrophysiology Research Laboratory, Texas Heart InstituteVascular and Medicinal Research, Texas Heart InstituteDepartment of Cardiology, Bethune International Peace HospitalAbstract Background Cardiac Ca2+/calmodulin-dependent protein kinase II (CaMKII) activation plays a critical role in cardiomyocyte (CM) apoptosis and arrhythmia. Functional ATP-sensitive potassium (KATP) channels are essential for cardiac protection during ischemia. In cultured CMs, L5 low-density lipoprotein (LDL) induces apoptosis and QTc prolongation. L5 is a highly electronegative and atherogenic aberrant form of LDL, and its levels are significantly higher in patients with cardiovascular-related diseases. Here, the role of L5 in cardiac injury was studied by evaluating the effects of L5 on CaMKII activity and KATP channel physiology in CMs. Methods Cultured neonatal rat CMs (NRCMs) were treated with a moderate concentration (ie, 7.5 μg/mL) of L5 or L1 (the least electronegative LDL subfraction). NRCMs were examined for apoptosis and viability, CaMKII activity, and the expression of phosphorylated CaMKIIδ and NOX2/gp91phox. The function of KATP and action potentials (APs) was analyzed by using the patch-clamp technique. Results In NRCMs, L5 but not L1 significantly induced cell apoptosis and reduced cell viability. Furthermore, L5 decreased Kir6.2 expression by more than 50%. Patch-clamp analysis showed that L5 reduced the KATP current (IKATP) density induced by pinacidil, a KATP opener. The partial recovery of the inward potassium current during pinacidil washout was susceptible to subsequent inhibition by the IKATP blocker glibenclamide. Suppression of IKATP by L5 significantly prolonged the AP duration. L5 also significantly increased the activity of CaMKII, the phosphorylation of CaMKIIδ, and the expression of NOX2/gp91phox. L5-induced apoptosis was prevented by the addition of the CaMKII inhibitor KN93 and the reactive oxygen species scavenger Mn (III)TBAP. Conclusions L5 but not L1 induces CM damage through the activation of the CaMKII pathway and increases arrhythmogenicity in CMs by modulating the AP duration. These results help to explain the harmful effects of L5 in cardiovascular-related disease.http://link.springer.com/article/10.1186/s12944-020-01368-7Action potentialATP-sensitive potassiumCa2+/calmodulin-dependent protein kinase IICardiomyocytesElectronegative low-density lipoprotein
collection DOAJ
language English
format Article
sources DOAJ
author Yanzhuo Ma
Nancy Cheng
Junping Sun
Jonathan Xuhai Lu
Shahrzad Abbasi
Geru Wu
An-Sheng Lee
Tatsuya Sawamura
Jie Cheng
Chu-Huang Chen
Yutao Xi
spellingShingle Yanzhuo Ma
Nancy Cheng
Junping Sun
Jonathan Xuhai Lu
Shahrzad Abbasi
Geru Wu
An-Sheng Lee
Tatsuya Sawamura
Jie Cheng
Chu-Huang Chen
Yutao Xi
Atherogenic L5 LDL induces cardiomyocyte apoptosis and inhibits KATP channels through CaMKII activation
Lipids in Health and Disease
Action potential
ATP-sensitive potassium
Ca2+/calmodulin-dependent protein kinase II
Cardiomyocytes
Electronegative low-density lipoprotein
author_facet Yanzhuo Ma
Nancy Cheng
Junping Sun
Jonathan Xuhai Lu
Shahrzad Abbasi
Geru Wu
An-Sheng Lee
Tatsuya Sawamura
Jie Cheng
Chu-Huang Chen
Yutao Xi
author_sort Yanzhuo Ma
title Atherogenic L5 LDL induces cardiomyocyte apoptosis and inhibits KATP channels through CaMKII activation
title_short Atherogenic L5 LDL induces cardiomyocyte apoptosis and inhibits KATP channels through CaMKII activation
title_full Atherogenic L5 LDL induces cardiomyocyte apoptosis and inhibits KATP channels through CaMKII activation
title_fullStr Atherogenic L5 LDL induces cardiomyocyte apoptosis and inhibits KATP channels through CaMKII activation
title_full_unstemmed Atherogenic L5 LDL induces cardiomyocyte apoptosis and inhibits KATP channels through CaMKII activation
title_sort atherogenic l5 ldl induces cardiomyocyte apoptosis and inhibits katp channels through camkii activation
publisher BMC
series Lipids in Health and Disease
issn 1476-511X
publishDate 2020-08-01
description Abstract Background Cardiac Ca2+/calmodulin-dependent protein kinase II (CaMKII) activation plays a critical role in cardiomyocyte (CM) apoptosis and arrhythmia. Functional ATP-sensitive potassium (KATP) channels are essential for cardiac protection during ischemia. In cultured CMs, L5 low-density lipoprotein (LDL) induces apoptosis and QTc prolongation. L5 is a highly electronegative and atherogenic aberrant form of LDL, and its levels are significantly higher in patients with cardiovascular-related diseases. Here, the role of L5 in cardiac injury was studied by evaluating the effects of L5 on CaMKII activity and KATP channel physiology in CMs. Methods Cultured neonatal rat CMs (NRCMs) were treated with a moderate concentration (ie, 7.5 μg/mL) of L5 or L1 (the least electronegative LDL subfraction). NRCMs were examined for apoptosis and viability, CaMKII activity, and the expression of phosphorylated CaMKIIδ and NOX2/gp91phox. The function of KATP and action potentials (APs) was analyzed by using the patch-clamp technique. Results In NRCMs, L5 but not L1 significantly induced cell apoptosis and reduced cell viability. Furthermore, L5 decreased Kir6.2 expression by more than 50%. Patch-clamp analysis showed that L5 reduced the KATP current (IKATP) density induced by pinacidil, a KATP opener. The partial recovery of the inward potassium current during pinacidil washout was susceptible to subsequent inhibition by the IKATP blocker glibenclamide. Suppression of IKATP by L5 significantly prolonged the AP duration. L5 also significantly increased the activity of CaMKII, the phosphorylation of CaMKIIδ, and the expression of NOX2/gp91phox. L5-induced apoptosis was prevented by the addition of the CaMKII inhibitor KN93 and the reactive oxygen species scavenger Mn (III)TBAP. Conclusions L5 but not L1 induces CM damage through the activation of the CaMKII pathway and increases arrhythmogenicity in CMs by modulating the AP duration. These results help to explain the harmful effects of L5 in cardiovascular-related disease.
topic Action potential
ATP-sensitive potassium
Ca2+/calmodulin-dependent protein kinase II
Cardiomyocytes
Electronegative low-density lipoprotein
url http://link.springer.com/article/10.1186/s12944-020-01368-7
work_keys_str_mv AT yanzhuoma atherogenicl5ldlinducescardiomyocyteapoptosisandinhibitskatpchannelsthroughcamkiiactivation
AT nancycheng atherogenicl5ldlinducescardiomyocyteapoptosisandinhibitskatpchannelsthroughcamkiiactivation
AT junpingsun atherogenicl5ldlinducescardiomyocyteapoptosisandinhibitskatpchannelsthroughcamkiiactivation
AT jonathanxuhailu atherogenicl5ldlinducescardiomyocyteapoptosisandinhibitskatpchannelsthroughcamkiiactivation
AT shahrzadabbasi atherogenicl5ldlinducescardiomyocyteapoptosisandinhibitskatpchannelsthroughcamkiiactivation
AT geruwu atherogenicl5ldlinducescardiomyocyteapoptosisandinhibitskatpchannelsthroughcamkiiactivation
AT anshenglee atherogenicl5ldlinducescardiomyocyteapoptosisandinhibitskatpchannelsthroughcamkiiactivation
AT tatsuyasawamura atherogenicl5ldlinducescardiomyocyteapoptosisandinhibitskatpchannelsthroughcamkiiactivation
AT jiecheng atherogenicl5ldlinducescardiomyocyteapoptosisandinhibitskatpchannelsthroughcamkiiactivation
AT chuhuangchen atherogenicl5ldlinducescardiomyocyteapoptosisandinhibitskatpchannelsthroughcamkiiactivation
AT yutaoxi atherogenicl5ldlinducescardiomyocyteapoptosisandinhibitskatpchannelsthroughcamkiiactivation
_version_ 1724496512537329664